Robot brain scanner could personalize blood pressure after spine surgery

NCT ID NCT06565442

Not yet recruiting Knowledge-focused Sponsor: University of Alabama at Birmingham Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jul 28, 2026 · Updated 3 times

Summary

This study tests whether a robot called NeuraSignal can measure blood flow in the brain of patients recovering from spinal surgery. The goal is to create personalized blood pressure targets for each patient. The study will include 20 adults in the neuro ICU. It is a feasibility study, meaning it checks if the robot works in this setting, not whether it improves health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: NeuraSignal transcranial doppler robot
What this could lead to: If successful, this could lead to a new way to personalize blood pressure management for patients after spinal surgery, potentially improving recovery.
What could go wrong: This is a very small, early feasibility study with only 20 people. It only tests if the robot can work in this setting, not if it improves outcomes. The robot may not be practical or accurate enough.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CEREBRAL AUTOREGULATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CEREBRAL AUTOREGULATION

Contacts and locations

Locations

UAB Department of Anesthesiology and Perioperative Medicine

Birmingham, Alabama, 35249, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.